![Carol-Ann Ohmstede](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Carol-Ann Ohmstede
No más puestos en curso
Historial de carrera de Carol-Ann Ohmstede
Antiguos cargos conocidos de Carol-Ann Ohmstede.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Trimeris, Inc.
![]() Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Corporate Officer/Principal | 01/01/1998 | - |
Formación de Carol-Ann Ohmstede.
University of South Florida | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 3 |
Operativa
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Trimeris, Inc.
![]() Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |
- Bolsa de valores
- Insiders
- Carol-Ann Ohmstede
- Experiencia